Ruxolitinib
✗High RID — 18.5% RID
Relative Infant Dose (RID)
18.5%
✓ Verified
Milk-to-Plasma Ratio (M:P)
Predicted
AI Predicted
What This Means
Ruxolitinib transfers a significant amount (18.5%) of the maternal dose through breast milk. Discuss alternatives and timing with your healthcare provider.
Important: This information is for educational purposes only. Always consult your healthcare provider before taking any medication while breastfeeding. Do not stop prescribed medications without medical advice.
Data source: ML Model Prediction • LactCheck by Benevolence Labs